Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Appointed director
CC transcript
|
|
ENZO BIOCHEM INC (ENZ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 6.4% stake in ENZO BIOCHEM, INC. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 3.7% stake in Enzo Biochem Inc. |
| 01/18/2022 |
SC 13G/A
| Evermore Global Advisors, LLC reports a 0% stake in Enzo Biochem, Inc. |
| 07/12/2021 |
SC 13G/A
| BlackRock Inc. reports a 3.2% stake in ENZO BIOCHEM INC |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 7.8% stake in ENZO BIOCHEM INC |
| 01/15/2021 |
SC 13G/A
| Evermore Global Advisors, LLC reports a 5.4% stake in Enzo Biochem, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7.8% stake in ENZO BIOCHEM INC |
| 01/30/2020 |
SC 13G/A
| Evermore Global Advisors, LLC reports a 8.4% stake in Enzo Biochem, Inc. |
| 01/29/2020 |
SC 13G/A
| WELLINGTON TRUST Co N A reports a 7.1% stake in Enzo Biochem, Inc. |
| 01/08/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 7.5% stake in Enzo Biochem, Inc. |
| 02/12/2019 |
SC 13G/A
| WELLINGTON TRUST Co N A reports a 8.2% stake in Enzo Biochem, Inc. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| Evermore Global Advisors, LLC reports a 9.6% stake in Enzo Biochem, Inc. |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/02/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2018 |
SC 13G/A
| WELLINGTON TRUST Co N A reports a 6.3% stake in Enzo Biochem, Inc. |
| 02/08/2018 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 9.2% stake in Enzo Biochem, Inc. |
| 01/29/2018 |
SC 13G/A
| BlackRock Inc. reports a 7.8% stake in ENZO BIOCHEM INC |
| 01/23/2018 |
SC 13G/A
| Evermore Global Advisors, LLC reports a 9.7% stake in Enzo Biochem, Inc. |
| 02/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2017 |
SC 13G/A
| Evermore Global Advisors, LLC reports a 7.2% stake in Enzo Biochem, Inc. |
| 02/11/2016 |
SC 13G/A
| DAVIDOWITZ ROSALIND reports a 4.9% stake in Enzo Biochem, Inc. |
| 02/14/2012 |
SC 13G/A
| Clearbridge Advisors, LLC reports a 6% stake in Enzo Biochem Inc Address of issuers principal executive offices: 60 Executive Blvd Farmingdale, NY 11735 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: Delaware Limited Liability Corporation Item 2d) |
| 02/13/2012 |
SC 13G/A
| ENZO BIOCHEM INC reports a 9.5% stake in Enzo Biochem, Inc. |
| 02/13/2012 |
SC 13G/A
| ENZO BIOCHEM INC reports a 8% stake in ENZO BIOCHEM INC |
| 10/05/2011 |
SC 13G/A
| ENZO BIOCHEM INC reports a 5.7% stake in Enzo Biochem Inc Address of issuers principal executive offices: 60 Executive Blvd Farmingdale, NY 11735 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: Delaware Limited Liability Corporation Item 2d) |
| 02/11/2011 |
SC 13G/A
| ENZO BIOCHEM INC reports a 13.3% stake in Enzo Biochem Inc Address of issuers principal executive offices 60 Executive Blvd Farmingdale, NY 11735 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: Delaware Limited Liability Corporation Item 2d) |
|
|
|